We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Delay

We will identify individuals at risk of developing T1D, allowing selection for cutting-edge immunotherapy trials to delay T1D progression.

Male scientist in a lab carrying out a procedure at a bench

Theme Lead

Rachel Besser

Consultant Paediatric endocrinologist and PI, Nuffield Department of Medicine

rachel.besser@well.ox.ac.uk

Researchers

John Todd

Professor of Precision Medicine
Holm Uhlig

Professor of Paediatric Gastroenterology
Katharine Owen

Associate Professor of Diabetes
Amanda Adler

Professor of Diabetic Medicine and Health Policy
Ruth Coleman

Head of Statistics & Modelling Group